Quantitative research has revealed upregulated levels of other proteases such as uPA (a serine protease) and its receptor uPAR as well as cathepsin B (a cysteine protease) in CNS tumors [33,34]. The gene discussed is CTSB; the disease is central nervous system neoplasm.